Tag: partners

Semtech AirLink XR60 5G router supports the Verizon Frontline Network Slice

WAYNE, Pa., June 25, 2025 (GLOBE NEWSWIRE) -- Elemica, the leader in network-based digital supply chain management and provider of the premier multi-enterprise digital supply chain network for all companies buying, selling and servicing the process manufacturing industry, today announced that its Sales Order Management & Collaboration solution has achieved SAP® certification as integrated with RISE with SAP S/4HANA^® Cloud. This integration helps organizations to more efficiently use Elemica’s Sales Order Management & Collaboration solution before, during and after their SAP S/4HANA migration.   

MONTREAL, June 25, 2025 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) is proud to announce that it has been named the top company in Corporate Knights’ annual ‘Best 50 Corporate Citizens’ ranking in Canada. This ranking recognizes companies that demonstrate outstanding leadership and commitment to sustainable development. This achievement highlights the importance Boralex places on corporate responsibility, which lies at the core of its business strategy.

HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTC: ASPZ), a clean energy technology company advancing advanced green methanol production systems, and hydrogen-based combustion systems for transport & off-grid power, is pleased to announce that Andrea Magalini has officially joined the Board of Directors as a Non-Executive Director.

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.

Bold Partner-led strategies continue to build momentum and produce all-time highs in Activation and Premium Memberships revenue